Perseus Holdings Leaders

About Us

Perseus Holdings USA, LLC is a Texas company with unique position of holding the executive licenses to bring a novel, safe and effective immunotherapy to market.

The technology currently in US FDA trials is based on the science and clinical successes of Dr. Thomas Wagner and his 52 years of work with cancer patients. In generally attacking cells in order to kill cancer cells, it would be more effective to use the immune system, which already recognizes cancer starts on a daily basis, to target a patient’s disease by targeting the particular antigenic and molecular profile of an individual patient’s cancer.

This antigenic and molecular profile is what the immune system needs to see in order to mount a strong response against it.